Ovicidal efficacy of high concentration dimeticone: A new era of head lice treatment - 10/08/11
Supported by G. Pohl-Boskamp GmbH & Co. KG (Hohenlockstedt, Germany). Dr Heukelbach is a research fellow from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil). Dr Sonnberg was supported by the German Research Foundation, PhD program (Graduiertenkolleg) 793. |
|
Conflicts of interest: Dr Heukelbach has been scientific consultant to G. Pohl-Boskamp GmbH & Co. KG, the manufacturer of NYDA. Dr Speare has been scientific consultant in the past to Emerald Forest Pharmaceuticals in trials on plant-based pediculicides, but currently has no links to the pharmaceutical industry. The other authors do not have any conflicts of interest to declare. |
Vol 64 - N° 4
P. e61-e62 - avril 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?